These results reinforce our conclusion that 5-Aza-CdR-induced ANO1 expression has positive impact on metastatic potential of prostate cancer cells and leads to osteolytic lesions by upregulating osteoclast differentiation at the metastatic bone lesion. This evidence concerns the gene ANO1 and prostate cancer.